Company intelligence / Profile preview

ECtel

Rosh Ha'ayin, Israel

Ownership: Private
Development stage: Other

Overview

ECtel was a global provider of revenue management and fraud prevention solutions, primarily serving the telecommunications industry but also expanding into the healthcare sector. The company's flagship platform, FraudView, was utilized by healthcare payers and providers to detect and prevent insurance fraud, waste, and abuse. By leveraging advanced data analytics and monitoring tools, ECtel helped organizations identify suspicious billing patterns and unauthorized claims in real-time. The company was publicly traded on NASDAQ under the symbol ECTL before being acquired by cVidya Networks in 2010.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on ECtel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ECtel.

Explore the full profile